| Item Type | Name |
|
Academic Article
|
Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
|
|
Academic Article
|
Potential markers that complement expression of CA125 in epithelial ovarian cancer.
|
|
Academic Article
|
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
|
|
Concept
|
Ki-67 Antigen
|
|
Concept
|
T-Cell Antigen Receptor Specificity
|
|
Concept
|
CA-125 Antigen
|
|
Concept
|
Antigen-Antibody Complex
|
|
Concept
|
Antigen-Antibody Reactions
|
|
Concept
|
Carcinoembryonic Antigen
|
|
Concept
|
Antigen-Presenting Cells
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Receptors, Antigen, B-Cell
|
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
|
Concept
|
CA-19-9 Antigen
|
|
Academic Article
|
CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer.
|
|
Academic Article
|
A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.
|
|
Academic Article
|
Naturally soluble tumor antigens from guinea pig hepatomas: isolation and partial characterization.
|
|
Academic Article
|
Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.
|
|
Academic Article
|
Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination.
|
|
Academic Article
|
Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody.
|
|
Academic Article
|
CA125 antigen levels in obstetric and gynecologic patients.
|
|
Academic Article
|
HL-A antigen frequency distribution in patients with gestational choriocarcinoma and their husbands.
|
|
Academic Article
|
Tumor marker guidelines.
|
|
Academic Article
|
Long-term follow-up of the Stockholm screening study on ovarian cancer.
|
|
Academic Article
|
Early detection of ovarian cancer: promise and reality.
|
|
Academic Article
|
Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer.
|
|
Academic Article
|
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.
|
|
Academic Article
|
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
|
|
Academic Article
|
Combined use of biomarkers for detection of ovarian cancer in high-risk women.
|
|
Academic Article
|
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders.
|
|
Academic Article
|
Coexpression of different antigenic markers on moieties that bear CA 125 determinants.
|
|
Academic Article
|
Preoperative serum tumor-associated antigen levels in women with pelvic masses.
|
|
Academic Article
|
Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen.
|
|
Academic Article
|
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.
|
|
Academic Article
|
Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas.
|
|
Academic Article
|
Determination of proliferation index in advanced ovarian cancer using quantitative image analysis.
|
|
Academic Article
|
Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection.
|
|
Academic Article
|
Guidelines for the use of carcinoembryonic antigen in colorectal cancer.
|
|
Academic Article
|
CA 125 in ovarian cancer: advances and controversy.
|
|
Academic Article
|
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
|
|
Academic Article
|
Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
|
|
Academic Article
|
New tumor markers: CA125 and beyond.
|
|
Academic Article
|
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
|
|
Academic Article
|
CA125/MUC16 is dispensable for mouse development and reproduction.
|
|
Academic Article
|
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.
|
|
Academic Article
|
CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease.
|
|
Academic Article
|
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
|
|
Academic Article
|
The role of tumor markers in gynecologic oncology.
|
|
Academic Article
|
Heterogeneity of antigen expression in advanced epithelial ovarian cancer.
|
|
Academic Article
|
Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
|
|
Academic Article
|
Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levels.
|
|
Academic Article
|
Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma.
|
|
Academic Article
|
Cutaneous basophil hypersensitivity. 3. Participation of the basophil in hypersensitivity to antigen-antibody complexes, delayed hypersensitivity and contact allergy. Passive transfer.
|
|
Academic Article
|
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas.
|
|
Academic Article
|
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen.
|
|
Academic Article
|
Immunologic approaches to the management of ovarian carcinoma.
|
|
Academic Article
|
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
|
|
Academic Article
|
Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer.
|
|
Academic Article
|
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
|
|
Academic Article
|
Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop.
|
|
Academic Article
|
Is OVX1 a suitable marker for endometrial cancer?
|
|
Academic Article
|
OVX1 and CEA in patients with colon carcinoma, colon polyps and benign colon disorders.
|
|
Academic Article
|
Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.
|
|
Academic Article
|
Status of tumor markers in ovarian cancer screening.
|
|
Academic Article
|
Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.
|
|
Academic Article
|
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
|
|
Academic Article
|
Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare.
|
|
Academic Article
|
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
|
|
Academic Article
|
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.
|
|
Academic Article
|
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
|
|
Academic Article
|
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
|
|
Academic Article
|
Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
|
|
Academic Article
|
Current state of biomarker development for clinical application in epithelial ovarian cancer.
|
|
Academic Article
|
Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.
|
|
Academic Article
|
Development of a multimarker assay for early detection of ovarian cancer.
|
|
Academic Article
|
More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis.
|
|
Academic Article
|
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
|
|
Academic Article
|
Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
|
|
Academic Article
|
Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.
|
|
Academic Article
|
Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.
|
|
Academic Article
|
The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas.
|
|
Academic Article
|
The use of tumor markers in the management of patients with gynecologic carcinomas.
|
|
Academic Article
|
A study of the NB/7OK and CA 125 monoclonal antibody radioimmunoassays for measuring serum antigen levels in ovarian cancer patients.
|
|
Academic Article
|
The CA 125 tumour-associated antigen: a review of the literature.
|
|
Academic Article
|
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.
|
|
Academic Article
|
Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
|
|
Academic Article
|
Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors.
|
|
Academic Article
|
Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis.
|
|
Academic Article
|
Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine.
|
|
Academic Article
|
CA 125: the past and the future.
|
|
Academic Article
|
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.
|
|
Academic Article
|
Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.
|
|
Academic Article
|
Sensitive and specific detection of the 4B5 antigen in bronchial lavage specimens from patients with primary bronchogenic carcinoma.
|
|
Academic Article
|
Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells.
|
|
Academic Article
|
Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer.
|
|
Academic Article
|
SCC antigen. Summary remarks.
|
|
Academic Article
|
Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.
|
|
Academic Article
|
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
|
|
Academic Article
|
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer.
|
|
Academic Article
|
Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.
|
|
Academic Article
|
A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
|
|
Academic Article
|
Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody
|
|
Academic Article
|
Clinical studies of an oncofetal antigen (DU-PAN-2) detected by a monoclonal antibody to pancreatic adenocarcinoma
|
|
Academic Article
|
Tissue distribution and characteristics of the CA 125 antigen
|
|
Academic Article
|
Biomarkers and Strategies for Early Detection of Ovarian Cancer.
|